Feds announce first Defence Industrial Strategy-related medical countermeasures project with $75-million for Canadian Blood Services
The focus shouldn’t just be on products, but process. The government needs to make sure Canada has the ability to quickly manufacture therapeutics in response to biothreats and health emergencies, says Northern RNA’s Thomas Hansen.
With a $75-million investment to Canadian Blood Services to increase domestic blood and plasma supplies for health emergencies, the federal Liberals have provided a first look at their plans to bolster Canada’s medical countermeasures, which were classified as a “soverei...
SPONSORED CONTENT
Get Tuesdays: Innovation & Industry Newsletter
The policies, decisions, and people working on investment and regulation in the industry and innovation realm.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
